Specialty: Breast Surgery, General Surgery
Sub-specialties: Minimally Invasive Breast Surgery (Endoscopic and Robotic), Breast Surgery, Oncoplastic Breast Surgery
Conditions Treated by this Doctor:
Abdominal Pain, Atypical Hyperplasia, Benign Breast Diseases, Breast Cancer , Breast Cancer - Diagnosis to Treatment, Breast Cancer - Early Detection and Screening, Breast Cancer (Breast Health), Duct Ectasia, Fibroadenoma, Fibrocystic Change, Gynaecomastia, Intraductal Papillomas, Lobular Carcinoma in Situ, Mastitis, Peptic Ulcer Disease (PUD), Per Rectal Bleeding, Pilonidal Disease.
Dr. Mok Chi Wei graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) on a Dean’s list in 2010 and subsequently joined Singhealth General Surgery Residency Programme from 2012 to 2017 for his postgraduate training. He was accredited as a specialist in general surgery in September 2017, with the fellowship examinations of the Royal College of Surgeons of Edinburgh (General Surgery), before sub-specialising in breast surgery in particular breast cancer surgery.
He is currently a consultant in the Department of Surgery, Changi General Hospital with a subspecialty interest in breast surgery. His clinical practice is mainly on breast diseases, both benign and malignant. He completed his advanced fellowship in oncoplastic and minimally invasive (endoscopic and robotic) breast surgery. Dr. Mok also believes that the appearance of the breast after cancer resection is extremely important. Apart from his clinical commitments, he also teaches undergraduate and postgraduate students from the Yong Loo Lin School of Medicine, Duke-NUS Medical School and Lee Kong Chian School of Medicine.
In terms of research, Dr. Mok has published extensively in breast cancer related topics and he also serves as a peer reviewer in Journal of Plastic & Reconstructive Surgery (JPRAS) and Journal of Surgery. Of note, he has recently co-authored the first textbook on minimally invasive (endoscopic and robotic) breast surgery techniques which was published by Elsevier in January 2020.
Subscribe to our mailing list to get the updates to your inbox